Global RNA Based Therapeutics Market 2024-2028

The RNA based therapeutics market is forecasted to grow by USD 1268.2 mn during 2023-2028, accelerating at a CAGR of 5.54% during the forecast period. The report on the RNA based therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing investment and funding in RNA based therapeutics, expansion of RNA based therapeutics through government authorization, and rising incidence of chronic and infectious diseases.

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	5.12%
CAGR	5.54%
Incremental Value	$1268.2 mn

Technavio's RNA based therapeutics market is segmented as below:

By Type

mRNA therapeutics
Antisense oligonucleotide (ASO) therapeutics
RNA interference (RNAi) therapeutics
Others

By Route Of Administration

Intravenous (IV)
Subcutaneous (SC)
Intramuscular (IM)

By Geographical Landscape

Europe
North America
Asia
Rest of World (ROW)

This study identifies the increasing collaborations and partnerships as one of the prime reasons driving the RNA based therapeutics market growth during the next few years. Also, developments in gene editing technologies and advancements in drug delivery systems will lead to sizable demand in the market.

The report on the RNA based therapeutics market covers the following areas:

RNA based therapeutics market sizing
RNA based therapeutics market forecast
RNA based therapeutics market industry analysis

The vendors analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading RNA based therapeutics market vendors that include Alnylam Pharmaceuticals Inc., Arbutus Biopharma Corp., Arcturus Therapeutics Holdings Inc., Arrowhead Pharmaceuticals Inc., Ascidian Therapeutics Inc, AstraZeneca PLC, Beam Therapeutics Inc., Benitec Biopharma Inc., Biogen Inc., BioNTech SE, BioSpace, Circular Genomics Inc., CureVac AG, Esperovax, Gennova Biopharmaceuticals Ltd, Ionis Pharmaceuticals Inc., Moderna Inc., Novartis AG, Novo Nordisk AS, Omega Therapeutics Inc., Sarepta Therapeutics Inc., Silence Therapeutics PLC, and Tevard Biosciences. Also, the RNA based therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR80100

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value Chain Analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2023
4.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

5 Historic Market Size

5.1 Global RNA Based Therapeutics Market 2018 - 2022
- Historic Market Size - Data Table on Global RNA Based Therapeutics Market 2018 - 2022 ($ million)
5.2 Type segment analysis 2018 - 2022
- Historic Market Size - Type Segment 2018 - 2022 ($ million)
5.3 Route of Administration segment analysis 2018 - 2022
- Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
5.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
5.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

6 Qualitative Analysis

6.1 Impact of AI on the Global RNA Based Therapeutics Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
7.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

8 Market Segmentation by Type

8.1 Market segments
- Chart on Type - Market share 2023-2028 (%)
- Data Table on Type - Market share 2023-2028 (%)
8.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
8.3 mRNA therapeutics - Market size and forecast 2023-2028
- Chart on mRNA therapeutics - Market size and forecast 2023-2028 ($ million)
- Data Table on mRNA therapeutics - Market size and forecast 2023-2028 ($ million)
- Chart on mRNA therapeutics - Year-over-year growth 2023-2028 (%)
- Data Table on mRNA therapeutics - Year-over-year growth 2023-2028 (%)
8.4 Antisense oligonucleotide (ASO) therapeutics - Market size and forecast 2023-2028
- Chart on Antisense oligonucleotide (ASO) therapeutics - Market size and forecast 2023-2028 ($ million)
- Data Table on Antisense oligonucleotide (ASO) therapeutics - Market size and forecast 2023-2028 ($ million)
- Chart on Antisense oligonucleotide (ASO) therapeutics - Year-over-year growth 2023-2028 (%)
- Data Table on Antisense oligonucleotide (ASO) therapeutics - Year-over-year growth 2023-2028 (%)
8.5 RNA interference (RNAi) therapeutics - Market size and forecast 2023-2028
- Chart on RNA interference (RNAi) therapeutics - Market size and forecast 2023-2028 ($ million)
- Data Table on RNA interference (RNAi) therapeutics - Market size and forecast 2023-2028 ($ million)
- Chart on RNA interference (RNAi) therapeutics - Year-over-year growth 2023-2028 (%)
- Data Table on RNA interference (RNAi) therapeutics - Year-over-year growth 2023-2028 (%)
8.6 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ million)
- Data Table on Others - Market size and forecast 2023-2028 ($ million)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)
8.7 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)

9 Market Segmentation by Route of Administration

9.1 Market segments
- Chart on Route of Administration - Market share 2023-2028 (%)
- Data Table on Route of Administration - Market share 2023-2028 (%)
9.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
9.3 Intravenous (IV) - Market size and forecast 2023-2028
- Chart on Intravenous (IV) - Market size and forecast 2023-2028 ($ million)
- Data Table on Intravenous (IV) - Market size and forecast 2023-2028 ($ million)
- Chart on Intravenous (IV) - Year-over-year growth 2023-2028 (%)
- Data Table on Intravenous (IV) - Year-over-year growth 2023-2028 (%)
9.4 Subcutaneous (SC) - Market size and forecast 2023-2028
- Chart on Subcutaneous (SC) - Market size and forecast 2023-2028 ($ million)
- Data Table on Subcutaneous (SC) - Market size and forecast 2023-2028 ($ million)
- Chart on Subcutaneous (SC) - Year-over-year growth 2023-2028 (%)
- Data Table on Subcutaneous (SC) - Year-over-year growth 2023-2028 (%)
9.5 Intramuscular (IM) - Market size and forecast 2023-2028
- Chart on Intramuscular (IM) - Market size and forecast 2023-2028 ($ million)
- Data Table on Intramuscular (IM) - Market size and forecast 2023-2028 ($ million)
- Chart on Intramuscular (IM) - Year-over-year growth 2023-2028 (%)
- Data Table on Intramuscular (IM) - Year-over-year growth 2023-2028 (%)
9.6 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)

10 Customer Landscape

10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

11.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
11.3 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
11.4 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
11.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
11.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
11.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
11.8 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
11.9 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
11.10 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
11.11 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)
11.12 France - Market size and forecast 2023-2028
- Chart on France - Market size and forecast 2023-2028 ($ million)
- Data Table on France - Market size and forecast 2023-2028 ($ million)
- Chart on France - Year-over-year growth 2023-2028 (%)
- Data Table on France - Year-over-year growth 2023-2028 (%)
11.13 Italy - Market size and forecast 2023-2028
- Chart on Italy - Market size and forecast 2023-2028 ($ million)
- Data Table on Italy - Market size and forecast 2023-2028 ($ million)
- Chart on Italy - Year-over-year growth 2023-2028 (%)
- Data Table on Italy - Year-over-year growth 2023-2028 (%)
11.14 India - Market size and forecast 2023-2028
- Chart on India - Market size and forecast 2023-2028 ($ million)
- Data Table on India - Market size and forecast 2023-2028 ($ million)
- Chart on India - Year-over-year growth 2023-2028 (%)
- Data Table on India - Year-over-year growth 2023-2028 (%)
11.15 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
11.16 Singapore - Market size and forecast 2023-2028
- Chart on Singapore - Market size and forecast 2023-2028 ($ million)
- Data Table on Singapore - Market size and forecast 2023-2028 ($ million)
- Chart on Singapore - Year-over-year growth 2023-2028 (%)
- Data Table on Singapore - Year-over-year growth 2023-2028 (%)
11.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

12 Drivers, Challenges, and Opportunity/Restraints

12.1 Market drivers
12.2 Market challenges
12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
12.4 Market opportunities/restraints

13 Competitive Landscape

13.1 Overview
13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
- Overview on factors of disruption
13.4 Industry risks
- Impact of key risks on business

14 Competitive Analysis

14.1 Companies profiled
- Companies covered
14.2 Company ranking index
- Company ranking index
14.3 Market positioning of companies
- Matrix on companies position and classification
14.4 Alnylam Pharmaceuticals Inc.
- Alnylam Pharmaceuticals Inc. - Overview
- Alnylam Pharmaceuticals Inc. - Product / Service
- Alnylam Pharmaceuticals Inc. - Key offerings
- SWOT
14.5 Arbutus Biopharma Corp.
- Arbutus Biopharma Corp. - Overview
- Arbutus Biopharma Corp. - Product / Service
- Arbutus Biopharma Corp. - Key offerings
- SWOT
14.6 Arcturus Therapeutics Holdings Inc.
- Arcturus Therapeutics Holdings Inc. - Overview
- Arcturus Therapeutics Holdings Inc. - Product / Service
- Arcturus Therapeutics Holdings Inc. - Key offerings
- SWOT
14.7 Arrowhead Pharmaceuticals Inc.
- Arrowhead Pharmaceuticals Inc. - Overview
- Arrowhead Pharmaceuticals Inc. - Product / Service
- Arrowhead Pharmaceuticals Inc. - Key offerings
- SWOT
14.8 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- SWOT
14.9 Benitec Biopharma Inc.
- Benitec Biopharma Inc. - Overview
- Benitec Biopharma Inc. - Product / Service
- Benitec Biopharma Inc. - Key offerings
- SWOT
14.10 Biogen Inc.
- Biogen Inc. - Overview
- Biogen Inc. - Product / Service
- Biogen Inc. - Key news
- Biogen Inc. - Key offerings
- SWOT
14.11 BioNTech SE
- BioNTech SE - Overview
- BioNTech SE - Product / Service
- BioNTech SE - Key offerings
- SWOT
14.12 CureVac AG
- CureVac AG - Overview
- CureVac AG - Product / Service
- CureVac AG - Key offerings
- SWOT
14.13 Gennova Biopharmaceuticals Ltd
- Gennova Biopharmaceuticals Ltd - Overview
- Gennova Biopharmaceuticals Ltd - Product / Service
- Gennova Biopharmaceuticals Ltd - Key offerings
- SWOT
14.14 Ionis Pharmaceuticals Inc.
- Ionis Pharmaceuticals Inc. - Overview
- Ionis Pharmaceuticals Inc. - Product / Service
- Ionis Pharmaceuticals Inc. - Key news
- Ionis Pharmaceuticals Inc. - Key offerings
- SWOT
14.15 Moderna Inc.
- Moderna Inc. - Overview
- Moderna Inc. - Product / Service
- Moderna Inc. - Key offerings
- SWOT
14.16 Novo Nordisk AS
- Novo Nordisk AS - Overview
- Novo Nordisk AS - Business segments
- Novo Nordisk AS - Key news
- Novo Nordisk AS - Key offerings
- Novo Nordisk AS - Segment focus
- SWOT
14.17 Sarepta Therapeutics Inc.
- Sarepta Therapeutics Inc. - Overview
- Sarepta Therapeutics Inc. - Product / Service
- Sarepta Therapeutics Inc. - Key offerings
- SWOT
14.18 Silence Therapeutics plc
- Silence Therapeutics plc - Overview
- Silence Therapeutics plc - Product / Service
- Silence Therapeutics plc - Key offerings
- SWOT

15 Appendix

15.1 Scope of the report
15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
15.3 Currency conversion rates for US$
- Currency conversion rates for US$
15.4 Research methodology
- Research methodology
15.5 Data procurement
- Information sources
15.6 Data validation
- Data validation
15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
15.8 Data synthesis
- Data synthesis
15.9 360 degree market analysis
- 360 degree market analysis
15.10 List of abbreviations
- List of abbreviations